[go: up one dir, main page]

ES2099272T3 - Composiciones oftalmicas a base de oxicam o de derivados de oxicam. - Google Patents

Composiciones oftalmicas a base de oxicam o de derivados de oxicam.

Info

Publication number
ES2099272T3
ES2099272T3 ES92916114T ES92916114T ES2099272T3 ES 2099272 T3 ES2099272 T3 ES 2099272T3 ES 92916114 T ES92916114 T ES 92916114T ES 92916114 T ES92916114 T ES 92916114T ES 2099272 T3 ES2099272 T3 ES 2099272T3
Authority
ES
Spain
Prior art keywords
oxicam
compositions based
derivatives
ophthalmic compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92916114T
Other languages
English (en)
Inventor
Gerard Schwadrohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROPHTA LAB
Original Assignee
EUROPHTA LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUROPHTA LAB filed Critical EUROPHTA LAB
Application granted granted Critical
Publication of ES2099272T3 publication Critical patent/ES2099272T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION CONCIERNE A NUEVAS COMPOSICIONES FARMACEUTICAS DESTINADAS AL USO OFTALMICO. CONCIERNE EN PARTICULAR A COMPOSICIONES OFTALMICAS INSTILABLES DE VISCOSIDAD MEDIA CARACTERIZADAS EN QUE CONTIENEN COMO PRINCIPIO ACTIVO UN AGENTE ANTIINFLAMATORIO ASOCIADO EVENTUALMENTE A UN AGENTE ANTIBACTERIANO Y A UN POLIMERO DE ACIDO ACRILICO CONGELANTE Y UN AGENTE BASICO DE MANERA QUE OBTENGA SOLUTO ACUOSO, FLUIDO, QUE TIENE UN PH COMPRENDIDO ENTRE 7,0 Y 8,0. LAS COMPOSICIONES SEGUN LA INVENCION SON UTILES PARA EL TRATAMIENTO DE LAS MANIFESTACIONES INFLAMATORIAS PATOLOGICAS DE LA ESFERA OCULAR.
ES92916114T 1991-07-18 1992-07-17 Composiciones oftalmicas a base de oxicam o de derivados de oxicam. Expired - Lifetime ES2099272T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109096A FR2679135B1 (fr) 1991-07-18 1991-07-18 Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.

Publications (1)

Publication Number Publication Date
ES2099272T3 true ES2099272T3 (es) 1997-05-16

Family

ID=9415269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92916114T Expired - Lifetime ES2099272T3 (es) 1991-07-18 1992-07-17 Composiciones oftalmicas a base de oxicam o de derivados de oxicam.

Country Status (10)

Country Link
EP (1) EP0594770B1 (es)
AT (1) ATE147627T1 (es)
AU (1) AU2388392A (es)
DE (1) DE69216831T2 (es)
DK (1) DK0594770T3 (es)
ES (1) ES2099272T3 (es)
FI (1) FI107700B (es)
FR (1) FR2679135B1 (es)
NO (1) NO940160L (es)
WO (1) WO1993001814A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005004876A1 (es) * 2003-07-10 2005-01-20 Arturo Jimenez Bayardo Metodo para preparar una solucion acuosa de meloxicam y solucion acuosa resultante

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19511322C2 (de) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
WO1999009988A1 (en) * 1997-08-27 1999-03-04 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
JP4234907B2 (ja) * 1998-05-15 2009-03-04 わかもと製薬株式会社 抗炎症点眼剤
AU1548001A (en) * 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
SG176525A1 (en) 2006-12-22 2011-12-29 Sigma Tau Ind Farmaceuti Gel useful for the delivery of ophthalmic drugs
MX2012004177A (es) 2009-10-12 2012-05-08 Boehringer Ingelheim Vetmed Recipiente para composiciones que comprenden meloxicam.
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
JPS5913714A (ja) * 1982-07-13 1984-01-24 Taito Pfizer Kk 外用消炎鎮痛剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005004876A1 (es) * 2003-07-10 2005-01-20 Arturo Jimenez Bayardo Metodo para preparar una solucion acuosa de meloxicam y solucion acuosa resultante

Also Published As

Publication number Publication date
AU2388392A (en) 1993-02-23
FI107700B (fi) 2001-09-28
FI940224A0 (fi) 1994-01-17
FR2679135A1 (fr) 1993-01-22
NO940160L (no) 1994-03-04
EP0594770A1 (fr) 1994-05-04
EP0594770B1 (fr) 1997-01-15
DE69216831D1 (de) 1997-02-27
DE69216831T2 (de) 1997-07-31
NO940160D0 (no) 1994-01-17
FR2679135B1 (fr) 1995-05-19
WO1993001814A1 (fr) 1993-02-04
FI940224L (fi) 1994-03-14
ATE147627T1 (de) 1997-02-15
DK0594770T3 (da) 1997-07-21

Similar Documents

Publication Publication Date Title
ES2099272T3 (es) Composiciones oftalmicas a base de oxicam o de derivados de oxicam.
BR9910113A (pt) Composições oftálmicas que se transformam em gel, contendo goma xantano
BR0014203A (pt) Formulações de suspensão tópicas contendo ciprofloxacina e dexametasona
ES2148568T3 (es) Formulaciones de disoluciones acuosas estables de interferon alfa.
ES2169102T3 (es) (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central.
AR092919A2 (es) Composicion farmaceutica liquida
DE69333850D1 (de) Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
ES2161874T3 (es) Composicion oftalmica con viscosidad reducida.
ES2184306T3 (es) Soluciones de acondicionamiento para el cuidado de las lentes de contacto duras.
ES2081936T3 (es) Composiciones anfoteras y formas polimericas de alfa-hidroxiacidos, y su uso terapeutico.
ES2181473T3 (es) Formulaciones liquidas estables de la toxina botulinica.
PE38897A1 (es) Solucion acuosa de interferon alfa
ES2086267T1 (es) Clonacion y expresion de genes de xilanasa de origen fungico.
SV2002000231A (es) Compuestos 2,4,-diaminopirimidina utiles como inmunosupresores ref. pc10547/20083/bb
ES2183486T3 (es) Formulaciones de fsh y de variantes de fsh que comprenden alcohol bencilico como agente preservativo.
ES2098323T3 (es) Sistema doble redox para la desinfeccion de lentes de contacto.
ES2194999T3 (es) Composicion para el tratamiento de heridas.
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
ES2190082T3 (es) Concentrados estables de vitamina c.
BRPI0417175A (pt) composições, método para produzir essas composições, solução que as compreende e métodos para utilizar as mesmas
ES2104571T3 (es) Composiciones concentradas de suspensiones acuosas.
ES2132241T3 (es) Composiciones oftalmicas y metodos para su conservacion y su empleo.
BRPI0408515A (pt) composições antimicrobianas; método de produção; solução e método para uso das mesmas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 594770

Country of ref document: ES